XGX Pharma ApS is a Danish APS based in København K, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2009, the company has 5 employees and reported revenue of 32,3 mio. kr. in its latest annual filing.
Selskabet tegnes af direktøren i forening med ét bestyrelsesmedlem
Company purpose
Selskabets formål er at drive virksomhed med fremstilling, markedsføring og distribution af medicinske produkter samt at udøve enhver aktivitet, der efter ledelsens skøn er forbundet hermed.
In its most recent annual report (2025), XGX Pharma ApS reported a gross profit of 32,3 mio. kr., an increase of 102% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of 16,1 mio. kr., and the EBITDA margin stood at 74.8%.
At the end of 2025, equity financed 55.9% of the balance sheet, and current assets covered short-term debt 1.7 times.
Frequently asked questions
What is the CVR number of XGX Pharma ApS?
XGX Pharma ApS is registered with CVR / Virk under CVR 32289290.
What is the revenue of XGX Pharma ApS?
XGX Pharma ApS reported revenue of 32,3 mio. kr. in 2025.
How many employees does XGX Pharma ApS have?
XGX Pharma ApS employs 5 people as of the latest annual report.
Who is the CEO of XGX Pharma ApS?
Jens-Nikolaj Schøier is the CEO of XGX Pharma ApS, in role since 2017.
Who is the chairman of XGX Pharma ApS?
Per Anders Larnholt chairs the board of XGX Pharma ApS, in role since 2025.
Where is XGX Pharma ApS headquartered?
XGX Pharma ApS's registered address is Frederiksgade 11, st. th.
